News|Articles|November 21, 2024
Ensure the Safety of Allogeneic Therapies with Advanced qPCR Testing
Author(s)Eurofins
Elevate your viral screening with Eurofins BioPharma Product Testing’s qPCR- based assays. Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
2
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One
3
PharmTech Weekly News Roundup — Week of October 27, 2025
4
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
5
